Search for Pharmacreams and
    1. Fast FT

      April 28, 2016

      AbbVie to acquire Stemcentrx in $5.8bn deal

      The pharmaceuticals M&A merry-go-round has started spinning fast again. In one of several deals announced on Thursday,...

    2. Fast FT

      February 3, 2016

      Merck falls as strong dollar weighs on revenue

      Merck has become the latest big drug maker to miss its revenue forecasts due to a stronger dollar, prompting its shares...

    Special Reports

    1. Innovation in Healthcare

      Health systems around the world face rising demand from an ageing population. More eff...
    Search more Special Reports on this topic.

    1. Fast FT

      January 26, 2016

      J&J's top line stung by dollar; profits rise

      Johnson & Johnson, the world’s largest healthcare company, has underlined the pain a stronger dollar is inflicting on...

    2. January 3, 2016

      GSK chief fights back to regain investor faith

      GlaxoSmithKline’s embattled chief executive is preparing to launch a big push to reset investor perceptions of the...

    3. Fast FT

      December 21, 2015

      Sun Pharma shares fall 7% after FDA warning

      Shares in Mumbai-based Sun Pharmaceuticals fell as much as 7.4 per cent on Monday after the US Food and Drug...

    4. December 19, 2015

      US FDA warns Sun Pharma for violating manufacturing standards

      India’s largest drugmaker, Sun Pharmaceuticals, said on Saturday that it had received a warning letter from the US Food...

    5. December 18, 2015

      Isis Pharmaceutical changes its name to Ionis

      When Isis Pharmaceuticals was founded 26 years ago, its name — inspired by the Greek goddess of magic and healing —...

    6. October 23, 2015

      Pandora underperforms on bullish tech day

      Pandora Media, the web radio company, lost more than a third of its value on Friday despite an otherwise bullish day...

    7. October 6, 2015

      Bristol-Myers to pay SEC $14m to settle China bribery claim

      US drugmaker Bristol-Myers Squibb is to pay $14m in penalties to US authorities over alleged “improper payments” made...

    8. June 5, 2015

      Cancer treatment: Healing powers

      It felt more like a gathering of Silicon Valley entrepreneurs than a mainstream medical meeting. But the 30,000...

    9. May 10, 2015

      GlaxoSmithKline chief seeks immunity from sector’s herd mentality

      Mergers and acquisitions may involve vast sums of money but they are as prone to fashion as anything else. Indeed, when...

    10. April 3, 2015

      Week in Review, April 4

      A round up of some of the week’s most significant corporate events and news stories. Pharma booster in busiest M&A...

    11. March 25, 2015

      Ranbaxy pledges to regain US trust

      The Indian pharmaceuticals tycoon Dilip Shangvi has vowed to do “whatever it takes” to restore US regulators’...

    12. March 19, 2015

      The charity that matches surplus medicine with acute need

      Pharmaceuticals executives might not seem the most likely recipients of hospitality from HRH the Prince of Wales. The...

    13. March 15, 2015

      Pharma sector hails ‘sea change’ in heart disease treatment

      The pharmaceuticals industry has hailed an impending “sea change” in the treatment of heart disease as it gears up to...

    14. February 25, 2015

      Pharmacyclics considers $19bn sale

      Pharmacyclics is considering a sale that could value the US cancer drugs maker at about $19bn, according to people...

    15. February 24, 2015

      Eli Lilly stays out of deals fray as it eyes ‘moon shot’ drugs

      The pharmaceutical industry is gripped by deals fever, but one company is conspicuously absent from the lists of...

    16. February 16, 2015

      Compound sharing boosts drugs success

      In every science-based industry, the 20th-century model of research and development carried out in closed corporate...

    17. December 26, 2014

      Big pharma cashes in as M&A fever sweeps sector

      It was a big year for big pharma as a succession of multibillion-dollar mergers and acquisitions swept the industry....

    18. August 12, 2014

      Intercept surges on liver treatment trial

      Intercept Pharmaceuticals shares surged after the biotech company said results from a mid-stage trial of a treatment...

    19. FT Alphaville

      August 6, 2014

      The Closer

      FURTHER FURTHER READING - The FT & McKinsey books of the year. - Demographics and 2020. - Shifts in US trading partners...

    20. May 28, 2014

      Cyber attackers ‘target healthcare and pharma companies’

      Healthcare companies have been more vulnerable to cyber attacks in the last year than even the retail industry, which...

    21. May 6, 2014

      Drug companies are built in labs, not boardrooms

      For most of the 20th century ICI was Britain’s leading industrial company. It was formed in 1926 through the merger of...

    22. April 16, 2014

      Reckitt Benckiser eyes pharmaceutical unit spin-off

      Reckitt Benckiser says it is leaning towards a spin-off of the pharmaceuticals division it put under strategic review...

    23. April 7, 2014

      India’s Sun Pharma offers $3.2bn for ailing Ranbaxy

      Sun Pharmaceutical Industries has agreed to pay $3.2bn for the equity in Ranbaxy, the Indian generic drugmaker that has...

    24. April 4, 2014

      Meda: nothing to sneeze at

      Bless you! Investors in Meda might have said on Friday. News of an (albeit rejected) approach to the Swedish pharma...

    25. FT Tech Hub

      March 19, 2014

      IBM's Watson finds a new challenge: personalised cancer treatment

      For its most promising new technology, IBM has been searching for problems to solve that are both deep and broad...

    26. March 12, 2014

      Bayer: high hopes

      The 2014 targets from Bayer: 5 per cent sales growth; growth in earnings before interest, tax, depreciation and...

    27. October 22, 2013

      Reckitt paves way for £2bn pharma arm sale

      Reckitt Benckiser has paved the way for the possible sale of its pharmaceuticals arm, which it considers non-core to...

    28. July 28, 2013

      Ireland’s ‘patent cliff’ poses problems for exit of bailout

      The metal reactors at Pfizer’s 200-acre manufacturing plant in Ringaskiddy that make the drug Viagra are not as busy as...

    29. July 23, 2013

      Drug companies agree to release details of clinical studies

      European and US drug companies have agreed to share details of their clinical studies with independent researchers...

    30. April 24, 2013

      GlaxoSmithKline: replacing lost energy

      GlaxoSmithKline is putting away childish things. The pharmaceuticals group’s decision to sell Lucozade and Ribena will...

    31. April 2, 2013

      AstraZeneca loses US drug patent judgment

      AstraZeneca’s portfolio of patent-protected drugs has been trimmed back after the pharmaceuticals group lost a legal...

    32. March 5, 2013

      Margins give the little guys a chance

      Margins are an issue of profound importance for any business. But how much scientific thinking is there on the subject?...

    33. February 25, 2013

      Ireland ripe for M&A surge, says report

      Ireland is ripe for a surge in mergers and acquisitions as its economy starts to recover, in spite of fears that the...

    34. February 25, 2013

      Reckitt Benckiser: motorcycle maintenance

      Like a motorcycle attached to a creaky sidecar, Reckitt Benckiser is being dragged back by something it does not really...

    35. January 31, 2013

      AstraZeneca warns of tough year ahead

      AstraZeneca’s new chief executive expressed openness to large, “disruptive” acquisitions, while stressing his primary...

    36. December 21, 2012

      Young entrepreneurs thrive in Myanmar

      At midnight on the roof terrace of The Street Bar & Restaurant in central Yangon, a DJ mixes rhythmic Myanmar rap with...

    37. December 6, 2012

      Court of Justice upholds AstraZeneca fine

      Europe’s highest court has upheld a €53m fine against AstraZeneca, in a closely watched case that penalised the...

    38. November 30, 2012

      ‘Tis the season to be wary as gifts roll in

      It’s that time of year again. The time of year when the in-trays of procurement managers, regulators, not to mention...

    Search for Pharmacreams and